RYAN ARGYROS: Open Payments
NPI 1750933669 · WAIPAHU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 44 payments from 16 companies in 2025. Trend: 2023 $1,693 · 2024 $1,920 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $152 |
| AstraZeneca Pharmaceuticals LP | 5 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $108 |
| Amgen Inc. | 4 | $102 |
| Ardelyx, Inc. | 4 | $92 |
| Calliditas Therapeutics US Inc. | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| ANI Pharmaceuticals, Inc. | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
Products named: JARDIANCE, FARXIGA, Kerendia, KRYSTEXXA, IBSRELA, TARPEYO, PURIFIED CORTROPHIN GEL, Fabhalta.
Industry payments across HI — which companies pay providers there.
